CALA vs. SCPS, OBSV, STAB, AMPE, ATHX, IGNY, PKBO, PTEIQ, SMFL, and NOVNQ
Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Scopus BioPharma (SCPS), ObsEva (OBSV), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), Athersys (ATHX), Ignyte Acquisition (IGNY), Peak Bio (PKBO), PolarityTE (PTEIQ), Smart for Life (SMFL), and NVN Liquidation (NOVNQ). These companies are all part of the "medical" sector.
Calithera Biosciences (NASDAQ:CALA) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk.
Calithera Biosciences received 339 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 59.62% of users gave Calithera Biosciences an outperform vote.
Scopus BioPharma has lower revenue, but higher earnings than Calithera Biosciences.
In the previous week, Calithera Biosciences had 1 more articles in the media than Scopus BioPharma. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Scopus BioPharma. Calithera Biosciences' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score.
Summary
Calithera Biosciences beats Scopus BioPharma on 3 of the 5 factors compared between the two stocks.
Get Calithera Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CALA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Calithera Biosciences Competitors List
Related Companies and Tools
